TrkB control peptide (54-67), Purified Peptide-100 µg Reference: PE-1252-100 This peptide may be used to block binding activity of antibody to TrkB (# R-121-100).
Parkin control peptide (305-323), Purified Peptide-100 µg Reference: PE-1253-100 This peptide may be used to block binding activity of antibody to Parkin (# R-113-100).
Alpha synuclein control peptide (116-131), Purified Peptide-100 µg Reference: PE-1606-100 Alpha synuclein control peptide (116-131), Purified Peptide, suitable to Block.
Amyloid beta, 1-42, HFIP-treated Purified Peptide-50 μg Reference: PE-1749-50 Synthetic beta-amyloid Aβ1-42 was monomerized by HFIP (hexafluoro-2-propanol) treatment and dried. One vial contains 50 μg monomeric Aβ peptide that can be used to form solutions of unaggregated Aβ monomers, aggregated Aβ oligomers, Aβ fibrils and Aβ protein complexes according to published protocols, and used in a variety of research applications.
Amyloid beta, 1-42, oligomeric, Stabilized Peptide-2 x 500 ng Reference: PE-1750-1000 A proprietary preparation of human amyloid beta peptide (amino acids 1-42) that was initially monomerized by HFIP-treatment and then allowed to form oligomers by the procedure described in Youmans KL et al., 2012, followed by lyophilisation using Biosensis' proprietary stabilization procedures.The resulting oligomeric mixture has been specially designed to allow the formation of stable, oligomeric Aβ1-42 peptide, multimeric complexes or oligomers. The material is intended to be used as a stable and consistent standard or positive control for oligomeric ELISA assays, as well as other research applications.
Choline O-acetyltransferase (ChAT) control peptide (167-188), Purified... Reference: PE-1762-100 This peptide may be used to block binding activity of antibody to ChAT (# R-043-100 and # R-1621-100).
AGO1 | Argonaute 1, Blocking peptide Reference: AS09 527P Due to its low molecular weight, this peptide is not suitable for separation on a SDS gel,
Leucine-Rich Alpha-2-Glycoprotein NATIVE, Human Serum Reference: RD162183100 Native protein isolated from pooled human serum, 312 AA. MW: 34,35 kDa (calculated without glycosylation). Protein identity confirmed by LC-MS/MS (NCBI no. gi|16418467).
Alpha-1-Acid Glycoprotein NATIVE, Human serum Reference: RD162340500 Native protein isolated from human pooled serum, 183 AA, MW 21,560 kDa (calculated without glycosylation).
Prolactin-Inducible Protein NATIVE, Human seminal plasma Reference: RD164304050 Native protein isolated from pooled human seminal plasma, 118 AA, MW 13,52 kDa (calculated without glycosylation). Protein identity confirmed by LC-MS/MS (NCBI no. gi|4505821).
Annexin A2 NATIVE, Human Adipose Tissue Reference: RD165348025 Native protein isolated from Human Adipose Tissue, 338 AA, MW 38,472 kDa (calculated without glycosylation). Protein identity confirmed by MALDI-TOF/TOF (NCBI no. gi|4757756).
Lactoferrin NATIVE, Human Breast Milk Reference: RD1663441000 Native protein isolated from Human Breast Milk, 691 AA, MW 76,165 kDa (calculated without glycosylation). Protein identity confirmed by LC-MS/MS (NCBI no. gi|119585171).